We had recently shown that loss of the RNA-binding protein tristetraprolin (TTP), a key suppressor of inflammation, promotes tumor plasticity and resistance to enzalutamide in a mouse model of prostate adenocarcinoma (38). The gene discussed is ZFP36; the disease is prostate adenocarcinoma.